LAPUROON Aurora Vivid

Product Overview

LAPUROON Aurora Vivid is a South Korean PDRN-based skin booster formulated with 0.2% polydeoxyribonucleotide (PDRN) and 1% hyaluronic acid (HA). Part of the LAPUROON Aurora product range, Aurora Vivid combines sodium DNA with moisturizing and skin-conditioning ingredients, including peptides, amino acids, vitamins, and minerals. The product is supplied in five 5 mL vials, providing a total of 25 mL per box.

LAPUROON Aurora Vivid is positioned for professional aesthetic skincare applications focusing on hydration, skin texture, and overall skin appearance. Its formulation combines the water-binding properties of hyaluronic acid with PDRN and other ingredients associated with skin-conditioning and tissue-maintenance pathways.

The LAPUROON brand incorporates a proprietary formulation concept referred to as Neo-PDRN Technology, which combines PDRN with complementary active ingredients. Aurora Vivid is distinguished from Aurora Super by its lower PDRN concentration and larger vial-based packaging.

This product page provides professional buyers with information about LAPUROON Aurora Vivid's ingredients, concentrations, packaging, formulation characteristics, and product-specific considerations.

Key Features

• 0.2% PDRN: Contains 0.2% polydeoxyribonucleotide, also identified as sodium DNA, a DNA-derived ingredient investigated for its involvement in tissue-repair and cellular-maintenance pathways.
• 1% Hyaluronic Acid: Formulated with 1% HA, equivalent to 10 mg/mL, providing a hydrophilic component associated with moisture retention and skin hydration.
• Multi-Ingredient Skin Booster: Combines PDRN and HA with additional skin-conditioning ingredients, including peptides, amino acids, vitamins, minerals, and other formulation components.
• Neo-PDRN Formulation Concept: Uses the LAPUROON brand's combination of PDRN and complementary ingredients, marketed as Neo-PDRN Technology.
• 5 mL Vial Presentation: Supplied in a standard commercial configuration of five 5 mL vials, providing 25 mL of solution per box.

Composition & Specifications

LAPUROON Aurora Vivid combines sodium DNA (PDRN) and hyaluronic acid as its principal identified ingredients. Official LAPUROON product information specifies 0.2% PDRN and 1% HA for the Aurora Vivid formulation.

Additional ingredient categories described in brand and distributor documentation include peptides, amino acids, vitamins, minerals, mannitol, and coenzymes. Complete ingredient concentrations are not consistently disclosed in the available public product specifications.

Polydeoxyribonucleotide (PDRN)

PDRN is a DNA-derived polymer consisting of deoxyribonucleotide sequences. It is commonly identified in cosmetic ingredient declarations as sodium DNA.

Experimental and clinical research involving selected PDRN preparations has investigated biological responses related to tissue repair, inflammation, cellular proliferation, and extracellular matrix regulation.

The concentration of PDRN in LAPUROON Aurora Vivid is 0.2%, corresponding to 2 mg/mL when expressed as a weight-per-volume concentration.

Hyaluronic Acid (HA)

Hyaluronic acid is a naturally occurring glycosaminoglycan present in the extracellular matrix of connective tissues. Its molecular structure allows it to associate with water and contribute to tissue hydration and viscoelasticity.

LAPUROON Aurora Vivid contains 1% HA, equivalent to 10 mg/mL. This hydrophilic ingredient provides the principal moisture-binding component of the formulation.

Additional Skin-Conditioning Ingredients

The LAPUROON product family incorporates additional ingredients intended to complement its PDRN and HA formulation. Published descriptions identify peptides, amino acids, vitamins, minerals, mannitol, and coenzymes.

Peptides are short chains of amino acids that may perform signaling or structural functions depending on their specific sequences. Amino acids participate in protein synthesis and numerous cellular metabolic processes.

Vitamins and minerals support various biological processes, including enzymatic activity and antioxidant defense. Mannitol is a polyol commonly used in pharmaceutical and cosmetic formulations for its physicochemical characteristics.

Additional ingredients such as glutathione, retinol, ascorbic acid, and growth factor-related components appear in some commercial product descriptions. However, a complete quantitative ingredient declaration for the exact Aurora Vivid formulation has not been consistently verified. Their presence and concentrations should be confirmed against the supplied product's original documentation.

How LAPUROON Aurora Vivid Works

LAPUROON Aurora Vivid combines ingredients associated with skin hydration, cellular maintenance, and extracellular matrix biology. The principal formulation components are PDRN and hyaluronic acid.

PDRN and Tissue-Maintenance Pathways

Polydeoxyribonucleotide has been investigated for its interactions with biological pathways involved in tissue repair and regeneration.

Research involving selected PDRN preparations has described activity associated with adenosine A2A receptor signaling and nucleotide salvage pathways. These processes have been studied in relation to inflammation regulation, fibroblast activity, and extracellular matrix maintenance.

Experimental findings provide a scientific basis for investigating PDRN-containing formulations in dermatological applications. However, results obtained with other PDRN preparations cannot automatically establish the clinical effectiveness of LAPUROON Aurora Vivid.

Hyaluronic Acid and Moisture Retention

Hyaluronic acid is highly hydrophilic and contributes to water retention within biological tissues. Its presence in the extracellular matrix helps maintain tissue hydration and mechanical properties.

In LAPUROON Aurora Vivid, the 1% HA component provides moisture-binding properties that support the product's positioning as a hydration-focused skin booster.

The actual performance of HA depends on its molecular characteristics, formulation environment, and permitted application method.

Neo-PDRN Technology

LAPUROON describes its formulation concept as Neo-PDRN Technology, combining PDRN with other skin-conditioning ingredients to support the product's overall formulation objectives.

The brand associates this approach with improved skin hydration, texture, and radiance. These characteristics represent manufacturer-reported product positioning rather than independently established clinical outcomes for Aurora Vivid.

Ingredient-level research does not establish clinically proven synergy, treatment duration, or guaranteed skin regeneration for the finished LAPUROON Aurora Vivid formulation.

Aurora Vivid Formulation Characteristics

Within the LAPUROON Aurora range, Aurora Vivid is the vial-based formulation containing 0.2% PDRN and 1% HA. The product is positioned around hydration, skin conditioning, and improvement of the appearance of dull or dry skin.

Its principal identifying characteristics are the following:

• PDRN-Based Skin Conditioning: Contains sodium DNA as a principal ingredient within the LAPUROON formulation platform.
• Hydration-Focused Composition: Includes 1% hyaluronic acid for its established water-binding properties.
• Multi-Component Formulation: Incorporates additional ingredients associated with skin conditioning and maintenance.
• Larger Container Volume: Uses a 5 mL vial presentation rather than the smaller pre-filled syringe format found elsewhere in the LAPUROON Aurora range.

Aurora Vivid should be identified by its own 0.2% PDRN concentration and 5 mL vial presentation. Specifications from other LAPUROON products must not be substituted for those of Aurora Vivid.

Packaging & Product Presentation

LAPUROON Aurora Vivid is supplied as a liquid formulation in individual 5 mL vials. The documented standard packaging contains five vials per box.

The five-vial configuration is documented in the LAPUROON product range and Starpharmtec's product specifications. Individual vial listings may also appear in commercial distribution channels.

Verify whether the selected TEOSQUARE product option refers to a single 5 mL vial or a complete five-vial box. Container volume does not establish an administration quantity or permitted application method.

Storage & Handling

LAPUROON Aurora Vivid should be stored and handled according to the original product label and manufacturer-issued instructions. A definitive numerical storage temperature range has not been established from the available official product specifications.

• Original Packaging: Keep the product in its original container and packaging until required for its permitted use.
• Storage Conditions: Follow the temperature and environmental requirements stated on the supplied product label.
• Container Integrity: Inspect the vial and closure for visible damage, leakage, or signs of compromised packaging.
• Product Identification: Confirm the product name, PDRN concentration, container volume, lot number, and expiration date.
• Handling: Follow the manufacturer-issued instructions applicable to the specific supplied product and market.

Do not assume storage temperatures or handling requirements based on other PDRN skin boosters. The original market-specific product documentation takes precedence.

Safety & Regulatory Considerations

LAPUROON Aurora Vivid is marketed internationally as a professional PDRN skin booster. However, its legal product classification, permitted application methods, and regulatory authorization must be verified for the specific destination country.

The presence of PDRN, hyaluronic acid, peptides, vitamins, and other skin-conditioning ingredients does not independently establish safety or suitability for invasive administration.

Product presentation in a vial does not by itself indicate that a formulation is authorized for injection. Professional users must verify the intended application route and instructions specified in the original manufacturer documentation.

Individuals may experience irritation or hypersensitivity to specific formulation components. Where an invasive application is legally authorized, additional risks may include localized inflammation, infection, bruising, swelling, and other procedure-related complications.

Claims of guaranteed rejuvenation, immediate collagen regeneration, permanent improvement, or complete absence of adverse reactions should not be inferred from the ingredient composition.

This description is intended for professional product identification and commercial comparison. It does not constitute clinical guidance, establish patient suitability, or authorize any application method beyond the product's approved labeling.

Frequently Asked Questions